Category : Original Articles

ORIGINAL ARTICLE – Thoracic epidural for post-thoracotomy and thoracomyoplasty pain: a comparative study of three concentrations of fentanyl with plain ropivacaine

Ajay Kr Chaudhary*, Dinesh Singh**, Jai Shri Bogra***, Sulekha Saxena****,

Girish Chandra*****,Shashi Bhusan*****, Prithvi Kr Singh******

*Assistant Professor; **Associate Professor; ***Professor and Head; ****MD Student;******Professor *****PhD Fellow

Department of Anaesthesiology, K.G.M.College, Lucknow (UP), (India) 226003

Correspondence: Dr. Sulekha Saxena, Department of Anaesthesiology,King George’sMedical University Lucknow (UP), (India) 226003;


Aim: Optimum pain relief after thoracotomy is essential to reduce atelectasis and postoperative pneumonias. The aim of this prospective, double blind, randomised controlled trial was to compare the analgesic and adverse effects of three concentrations of fentanyl with 0.2% ropivacaine in thoracic epidural in patients undergoing thoracotomy and thoracomyolpasty.

Methodology: After getting approval from Ethical Committee, this study was performed in 60 patients of either sex, aged 18-60 years, American Society of Anaesthesiology (ASA) grade I to III. Informed consent was taken from all of the patients, who were recruited and divided into three groups of 20 patients in each group. Patients scheduled for elective thoracotomy surgery were enrolled in the study. Patients with preexisting motor and sensory deficit, addicted to hypnosedative drugs, on chronic opioid or analgesic therapy, sensitive to local anaesthetic or study medication, or having contraindications to regional anesthesia were excluded from this study. In patients, with whom communication difficulties prevented reliable assessment, were also excluded. A standard general anesthesia technique was used with intubation and positive pressure ventilation.

Patients received either 2.5 µg/ml (Group I), 5.0 µg/ml (Group II) or 7.5 µg/ml of fentanyl (Group III) respectively, with ropivacaine 0.2% via thoracic epidural. Postoperatively, pain at rest, on coughing and with ambulation was assessed using a visual analogue scale (VAS) and observer verbal ranking score (OVRS) at 2, 6, 12 and 24 hours. Sedation scores were also noted. Adverse effects were simultaneously assessed.

Results: There was no significant difference in the baseline characteristics between the three groups. The number of patients with episodes of unsatisfactory pain relief, i.e. a VAS scores >40 and OVRS >2, at each of the four assessments postoperatively, was higher in Group I than with Group II or Group III (p < 0.05). In Group III, four (20%) patients had a sedation score >3 compared with one (5%) in Group II. No patient in Group I had a sedation score >3 (p < 0.05). In addition, 30% of the patients experienced pruritus in Group I compared with 10% and 5% in Group II and I respectively (p < 05). A similar number of patients had emetic symptoms in Group III (30%) as compared to 20% and 5% in Group II and Group I respectively (p < 05).

Conclusion: We conclude that ropivacaine 0.2%, when combined with fentanyl 5.0 µg/ml provides optimal balance between postoperative pain relief and sedation, when used in thoracic epidural for thoracotomy.

Keywords: Thoracic epidural; Pain; Fentanyl; Ropivacaine; Thoracotomy; Thoracomyolpasty; Pain relief; Visual analogue scale; VAS

Citation:Chaudhary AK, Singh D, Bogra JS, Saxena S, Chandra GC, Bhusan S, Singh PK. Thoracic epidural for post-thoracotomy and thoracomyoplasty pain: a comparative study of three concentrations of fentanyl with plain ropivacaine. Anaesth Pain & Intensive Care 2013;17(1):22-27


After thoracotomy, the sources of perceived pain are numerous, which are surgical incision, disruption of ribs and intercostal nerves, inflammation of chest wall structures adjacent to the incision, incision or crushing of pulmonary parenchyma or pleura, stretching of shoulder joint and placement of thoracostomy drainage tubes.1 Optimum pain relief is essential if the incidence of atelectasis and postoperative pneumonias are to be reduced.2,3 Patients must not only be pain free at rest but must also be able to breathe deeply, cough effectively and comply with postoperative physiotherapy. Additional challenges faced by clinicians in these patients include old age, malnourishment, and frequent co-existing cardio-respiratory diseases. A number of analgesic techniques have been used to achieve pain relief.3,4

Ropivacaine is an amino-amide local anaesthetic and a less toxic homolog of bupivacaine. It can produce excellent analgesia and result in less intense motor block than bupivacaine when given by epidural infusion.5 However, the incidence of hypotension with 0.5% ropivacaine is high and lower concentrations when used alone are likely to be less effective.6,7

Fentanyl is a short-acting lipophilic opioid analgesic developed fentanyl by assaying analogues of the structurally related drug pethidine for opioid activity. Epidural opioids have also been used after thoracotomy. There has been much interest in attempts to improve the quality of epidural opioid analgesia by the addition of a low concentration of local anesthetic to reduce the incidence of side-effects.7, 8 The important clinical question is what concentration of fentanyl in ropivacaine 0.2% will provide effective analgesia with minimal adverse effects after invasive thoracic surgery. Therefore, this prospective, randomized, double blind study was designed to compare the analgesic and adverse effects of three different concentrations of thoracic epidural fentanyl with 0.2% ropivacaine in patients undergoing thoracotomy and thoracomyolpasty.


The study was conducted in the Surgical Department, King George’s Medical University, Lucknow (India), between August 2011 to July 2012. After obtaining institutional ethical committee approval, 60 patients undergoing thoracotomies, aged 18–60 years, of either sex belonging to American Society of Anesthesiologists (ASA) physical status I-III were recruited in the study. A written informed consent was obtained from every enrolled patient. The patients were divided into three groups of 20 patients each. Patient, who refused to take part in the study, who had any contraindication for epidural anesthesia, had preexisting motor and sensory deficit, patients with previous thoracic surgeries or known drug allergies were excluded from the study.

Patients were randomized to receive one of three epidural solutions using a computer-generated table of random numbers. The drugs were prepared by the hospital pharmacist who did not take part in the study or administration of the drugs. The drugs were provided in 20 ml syringes labelled with the patient’s name and trial code. Thus, patients as well as staff in theatre and in the ward were blinded to the study solution. On arrival of the patient in the operating room, a peripheral venous line was secured and IV infusion was established. Oxygen supplementation was given to all the patients using Venturi mask. FEV1, FVC and PEFR were measured pre-operatively and post-operatively at 2, 6, 12 and 24 hours. All patients received a standardized anesthetic with midazolam 0.05 mg/kg and fentanyl 1 µg/kg IV. After pre-oxygenation for 5 min, general anesthesia was induced with propofol 2–3 mg/kg IV. Neuromuscular block was achieved with atracurium 0.5 mg/kg IV and trachea was intubated using an appropriate sized cuffed double-lumen endobronchial tube. Correct tube position was confirmed with help of stethoscope and EtCO2 and anesthesia was maintained with with halothane 0.5–1% in N2O and oxygen 50% each. Thoracic epidural catheter was inserted under the general anesthesia at T4/5 or T5/6 inter-space at this time and the study solution was administered as a bolus as follows;

Group I: Patients received 20 ml solution of 0.2% ropivacaine with 2.5 µg/ml fentanyl.

Group II: Patients received 20 ml solution of 0.2% ropivacaine with 5 µg/ml fentanyl.

Group III: Patients received 20 ml solution of 0.2% ropivacaine with 7.5 µg/ml fentanyl.

Surgical incision was allowed after 10 min of epidural bolus. At any time during surgery, if the mean arterial pressure and heart rate increased to ≥25% of baseline, supplemental analgesic in the form of fentanyl 1µg/kg IV was given. Any episode of hypotension (systolic arterial pressure <90 mmHg) excluding surgical blood loss was treated with incremental doses of ephedrine, and bradycardia (heart rate < 50/min) was treated with atropine. After one hour epidural infusion was given at a rate of 0.1 ml/kg/h using syringe pump. A rescue dose of 5 ml of the  supplementary infusion was given if VAS score for pain ≥40. Number of patients requiring supplementary fentanyl and the total dose of fentanyl used was noted.

On completion of surgery the patients were reversed with neostigmine 2.5 mg and glycopyrrolate 500 mcg. Patients were then managed in a post-anesthesia care unit (PACU) for 24 hours. Analgesia was assessed at 2, 6, 12 and 24 hours using a visual analogue scale (VAS) (0 = no pain; 100 = worst pain imaginable) both at rest, and with cough and ambulation, after extubation. Sedation scores were also judged by the observer (0= awake; 1 = mild sedation; 2 = moderate sedation, easily arousable; 3 = heavily sedated difficult to rouse; 4 = over sedated, unrousable).9

At a VAS score of ≥40 and OVRS ≥2 supplemental analgesic was given in the form of epidural bolus of 0.1 ml/kg solution. Any episodes of nausea and/or vomiting, pruritus, urinary retention, sedation and respiratory depression were recorded at the same time as pain scores and treated accordingly.

All statistical analyses were performed using SPSS for windowsvs. 15.0. Continuous variables were tested for normal distributionby the Kolmogorov–Smirnov test. Parametric data was compared using analysis of variance (ANOVA). Comparisons between groups at different time intervals were assessed by using paired t-test. All the categorical data was compared by using chi square test. A samplesize of 20 patients in each group was needed to detect an intergroup differenceof at least 20% ( = 0.01, two-sided,power = 95%) with two sample t-test.10 Data were collected by a blinded observer and are presented as mean ± SD or N (%). A p-value of < 0.05 was considered to be significant.


The three groups were comparable in age, weight, height, sex, ASA classification, lung function test, duration of surgery and other variables recorded before operation (p>0.05) (Table II). The percentage of the patients requiring supplementary fentanyl in the postoperative period was 80% and 30% in Group I and Group II respectively; none of the patients in Group III (7.5 µg/ml fentanyl group) required it (p<0.05). The total dose of supplementary fentanyl required was also significantly higher in Group I as compared to Group II. No patient in Group III required it (p <0.05) (Table III). Postoperative VAS score for pain ≥40 was registered in 80%, 30% and zero% of patients in Group I, II and III respectively requiring supplementary fentanyl (Figure 1).

Figure 1: Percentage of patients and VAS scores


Table II: Demographic characteristics and pre-operative variables of the three study groups


Group 1

Group 2

Group 3

Age (year)

45 ± 8

42 ± 18

43 ± 16

Sex (M:F)




Height (cm)

165 ± 15

170 ±15

168 ±18

Weight (kg)

68 ± 12

65 ± 14

70 ± 16

Duration of surgery (min)

145 ± 35

150 ± 30

148 ± 36





RR (per min)

22 ± 4

23 ± 4

22 ± 3

HR (per min)

82 ± 12

86 ± 14

80 ± 12

SAP (mmHg)

150 ± 28

142 ± 32

146 ± 30

FEV1 (forced expiratory volume in one second)(lit)

1.9 ± 0.3

2.0 ± 0.4

1.9 ± 0.2

FVC (forced vital capacity)(lit)

2.4 ± 0.6

2.5 ± 0.3

2.4 ± 0.4

REFR (peak expiratory flow rate)(lit/min)

390 ± 110

380 ± 120

395 ± 115


Table III: Intra-operative supplementary fentanyl requirement

Group I (n = 20)

Group II (n = 20)

Group III (n = 20)

Number of patients requiring supplementary fentanyl

16 (80%)

6 (30%)*


  Total dose of fentanyl (Mean ± SD) (in µg)

76 ± 22

42 ± 18*


* p < 0.05 (I vs II and I vs III)

+ p < 0.05 (II vs III)

None of the patients in the Group I had sedation (score ≥3) while in the Group II and III, 20% and 50% patients, respectively, had sedation (p < 0.05). Pruritus did not differ statistically among the groups though significantly higher incidence (30%) was observed in Group III (p<0.05). None of the patients in any of the groups complained of numbness or limb weakness. Incidence of hypotension and nausea was highest (30%) in Group III , but values were statistically comparable (p>0.05). One patient in each group had bradycardia that required treatment (Table IV).

Table IV: Comparison of adverse effects in three groups. Data expressed as N(%)

Adverse effects

Group I (n-20)

Group II (n-20)

Group III (n-20)

Sedation (≥3) score








Emetic symptoms
















FEV1, FVC and PEFR were all reduced to 40–50% of their preoperative values throughout the study period in all three groups.


Pain in thoracotomy arises as a result of severe chest wall trauma which includes fractured ribs and damaged peripheral nerves and central nervous system hypersensitivity. Thoracic pain cannot be controlled by chest wall immobilized; if secretions are to be cleaned, it must remain in constant motion, indeed vigorous motion. Incidence of pneumonia and atelectasis is to be reduced with pain relief after thoracotomy, thereby patients can take deep breath, cough effectively.

Our results show that significantly (P<0.01) more patients receiving epidural fentanyl 2.5 µg/ml in ropivacaine 0.2% had pain VAS>40 mm and OVRS>2 compared with those who received fentanyl 5 µg/ml or fentanyl 7.5 µg/ml, in ropivacaine 0.2 %. In addition, there was a tendency for a higher incidence of sedation scores >3 and of pruritus, in group III compared with groups II and I. No significant difference in nausea, hypotension and bradycardia between the three groups was detected.

Our results concur with those of a randomized controlled trial (RCT) of thoracic epidural fentanyl 2.5, 5, 10 and 20 µg/ml with no local anaesthetic.11 It was shown that there was a concentration-dependent reduction in pain intensity in patients undergoing thoracotomy for lung resection. With fentanyl 2.5 µg/ml, there was a significant decrease in proportion of patients with >50% reduction in pain scores, compared with higher concentrations (fentanyl 5, 10 and 20 µg/ml). 11

In another RCT comparing thoracic epidural fentanyl 1, 2 and 4 µg/ml in ropivacaine 0.2%, was used in patients undergoing major abdominal surgery. It was shown that pain intensity was significantly greater in patients receiving fentanyl 1 to 2 µg/ml than in those having fentanyl 4 µg/ml.12 These results were also similar to our results of better postoperative analgesia at 5 µg/ml.

Epidural local anesthetic agents have an established role in analgesia during thoracic surgery. Opioids administered via the epidural route have been found to be superior in terms of analgesia, side-effects, length of stay and postoperative complications after thoracotomy.13 Hypotension was the most common side-effect with the use of the above and ropivacaine 0.5% in thoracic epidural, occurring in 80% of cases of patients in whom satisfactory analgesia was achieved.7 The high incidence of hypotension with ropivacaine can be attributed to sympathetic block.14 Although epidural administration of opioids does not result in sympathetic block15 hypotension has been observed with an epidural fentanyl,16 which could be related to systemic uptake from epidural space. In view of these findings and to avoid hypotension associated with either a high concentration of ropivacaine or a high dose of fentanyl, we used a continuous infusion (2.5 µg/ml, 5 µg/ml and 7.5µg/ml) rather than bolus high doses of fentanyl in a lower concentration of ropivacaine (0.2%).

On demand patient-controlled epidural analgesia after thoracotomy and upper abdominal surgery using fentanyl 1 µg/ml with ropivacaine 0.125%, was assessed in a previous study.6 No significantly reduction in amount of supplementary fentanyl required, the pain scores or the side effects was noted. Taking this into consideration we chose to use three different concentrations of fentanyl in 0.2% ropivacaine in our study. It has been demonstrated that epidural fentanyl contributes significantly to the analgesia component of balanced anesthetic during lung surgery15. Our result showed that epidural fentanyl with ropivacaine produces analgesia and is concentration dependent. The duration and intensity of pain relief were increased when a higher concentration of the drug was given, up to a maximum concentration of 7.5µg/ml. More patients receiving epidural fentanyl 2.5µg/ml in ropivacaine 0.2% had pain (VAS ≥40) compared with those who received fentanyl 5.0µg/ml or 7.5µg/ml in ropivacaine 0.2% (Figure 1). Preoperative and postoperative thoracic epidural analgesia techniques have been assessed on post-thoracotomy pain: preoperative epidural analgesia was found to be an appropriate method and was more effective in preventing acute post-thoracotomy pain17.Taking this into consideration; we administered perioperative thoracic epidural analgesia in our study.

Different epidural analgesics and their effects on pulmonary function have been compared in the past9. Throughout the postoperative period, reductions of up to 70% of the preoperative values (FEV1, FVC and PEFR) were noticed in all the study groups that mean with the different concentrations of fentanyl used in our study, no difference was found among the groups with regard to pulmonary functions.

Epidural opioids are associated with dose-dependent adverse effects of sedation, pruritus, nausea and respiratory depression.18 In this regard, in our study a concentration of 5µg/ml fentanyl was found to be optimum. On the other hand, lower concentrations of epidural fentanyl (2.5µg/ml) do not provide high quality analgesia following thoracic surgery. In patients who receive insufficient analgesia, an alternative method of increasing the concentration of epidural opioids is to consider an additional drug, i.e. clonidine 19.

In our study there appeared to be an increased incidence of pruritus (30%) in patients receiving epidural fentanyl 7.5 µg/ml. Our findings are in accordance with those of the previous report.20

This trend is consistent with a RCT in which the incidence of pruritus increased from 17% at fentanyl 10 µg/ml, to 36% at fentanyl 20 µg/ml11. In other studies of lower fentanyl concentrations, this concentration dependent effect was also demonstrable. For instance, the incidence of pruritus was 23%, 8%, 4% and 4% in obstetric patients receiving epidural fentanyl of concentrations 4, 3, 2 and 1 µg/ml, respectively.21 Furthermore, in a RCT of 244 patients undergoing major abdominal surgery, thoracic epidural fentanyl 4 µg/ml was associated with a significantly (P<0.02) higher incidence of pruritus than fentanyl1 µg/ml to 2 µg/ml.12

Our study in which there was a tendency to increased sedation in 20% of patients in the 7.5 µg/ml fentanyl group had a sedation score ≥3, concurs with a study by Welchew and colleagues.11 He showed that increased sedation occurred at fentanyl 10, 20 µg/ml but not at fentanyl 2.5 µg/ml. In two other RCTs of patients receiving thoracic epidural fentanyl 1, 2 and 4 µg/ml in ropivacaine 0.2%, sedation scores were low and no significant difference in sedation was detected 12, 21.

In our study a significant difference in frequency of nausea and vomiting was found between the three treatment groups. The patients experiencing postoperative nausea and vomiting was the highest in the Group III (30%) as compared to Group I (5%) and Group II (20%). These results differs from results obtained in an earlier study.22  This difference may be because our patients received general anesthesia with epidural analgesia, while in the other studies mentioned the patients received only epidural anesthesia.

In our study, assessments were made in the first 24 h postoperatively, and so our results are restricted to this period only. After thoracotomy for lung resection, patients may continue to have an epidural catheter in situ for 3-5 days. Analgesic requirements are expected to be much reduced on day 3 compared with immediate postoperative period. Thus if this study was extended beyond the first 24 h, then it is likely that we would have recorded a progressive reduction in opioid consumption in all treatment groups. By day 3, opioid consumption would be low and any possible differences in pain scores and opioid related adverse effects would not be detectable between groups.


  • Werestricted our primary objective to the analgesic effects of different doses of thoracic epidural fentanyl with low dose ropivacaine, and did not record levels and duration of sensory and motor blocks in the postoperative period in different groups.
  • We ignored postoperative values of FEV1, FVC and PEFR and did not compare these with preoperative values, as we wished to remain focused on minimum number of primary and secondary objectives and avoid confusion.


In conclusion, our study has shown that thoracic epidural fentanyl 5 µg/ml or 7.5 µg/ml are associated with superior postoperative analgesia after thoracotomy compared with fentanyl 2.5 µg/ml, when used in conjunction with ropivacaine 0.2%. However, the use of fentanyl 7.5 µg/ml is associated with excessive sedation and pruritus. Therefore, epidural fentanyl 5 µg/ml in ropivacaine 0.2% appears to provide the optimal balance between pain relief and adverse effects following thoracic surgery.


  1. Sanjay OP, Kadam VR, Menezes J, Prashanth P, Tauro DI. Thoracic epidural infusions for post thoracotomy pain relief: a clinical study to compare the efficacy of fentanyl –bupivicaine mixtures versus fentanyl alone. Ind J Thorac Cardiovasc Surg 2003;19:113-118. [Medline]
  2. Gottschalk A, Cohen S, Yang S, Ochroch EA. Preventing and treating pain after thoracic surgery. Anesthesiology 2006;104:594–600 [Medline]
  3. Ng A, Swanevelder J. Pain relief after thoracotomy: is epidural analgesia the optimal technique? Br J Anaesth 2007;98(2):159–62. [Medline]
  4. Chia YY, Wei RJ, Chang HC, Liu K. Optimal duration of urinary catheterization after thoracotomy in patients under postoperative patient-controlled epidural analgesia. Acta Anaesthesiol Taiwan. 2009 Dec;47(4):173-9. doi: 10.1016/S1875-4597(09)60051-5. [Medline]
  5. Korula S, George GM, Ipe S, Abraham SP. Epidural anesthesia and post-operative analgesia for bilateral inguinal mesh hernioplasty: Comparison of quipotent doses of ropivacaine and bupivacaine. Saudi J Anaesth. 2011 Jul;5(3):277-81. doi: 10.4103/1658-354X.84101. [Medline]
  6. Shorrab NA, Abdel-Mageed, Siam UA & Metawea AA: Intermittent Thoracic Epidural Administration of Ropivacaine-Fentanyl versus Bupivacaine-Fentanyl after Thoracotomy. The Internet Journal of Anesthesiology. 2007 Volume 13 Number 1. DOI: 10.5580/256a.
  7. Sakai T, Tomiyasu S, Sumikawa K. Epidural ropivacaine infusion for the treatment of pain following axillary muscle-sparing thoracotomy: a dose-evaluation study. J Anesth. 2007;21(3):320-4. Epub 2007 Aug 1. [Medline]
  8. Singh V, Kanshal , D Yadav N, Gupta R,  Kumar S. Thoracic epidural for post-thoracotomy pain: a comparison of three concentrations of sufentanil in bupivacaine. SAJAA 2009; 15(2): 16-21. [SAJAA]
  9. Tan CNH, Guha A, Scawn ND, Pennefather, SH, Russel GN. Optimal concentration of epidural fentanyl in bupivacaine 0.1% after thoractomy. Br J Anaesth. 2004 May;92(5):670-4. [Medline]
  10. Murphy KR and Myors B. Statistical Power Analysis: A Simple and General Model for Traditional and Modern Hypothesis Tests 2nd Edn (Lawrence Erlbaum Associates, Mahwah, NJ). 2004.
  11. Gísli Vigfússon, Gísli H. Sigurðsson, Epidural pain management after open lateral thoracotomy: Female patients have better pain relief and need smaller amounts of analgesics than males, Scandinavian Journal of Pain 2012; 3(2): 108-111. [ScandinavianJournalofPain]
  12. Scott D, Blake D, Buckland M, Etches RHalliwell RMarsland C, et al. A comparison of epidural ropivacaine alone and in combination with 1, 2, and 4 µg/ml fentanyl for 72 hrs of postoperative analgesia after major abdominal surgery. Anesth Analg 1999 Apr;88(4):857-64. [Medline]
  13. Debrecini G, Molnar Z, Szelig L, Molnar TF. Continuous epidural or intercostal analgesia following thoracotomy: a prospective randomised double-blind clinical trial. Acta Anaesthesiol Scand 2003 Oct;47(9):1091-5. [Medline]
  14. Wattwil M, Sundberg A, Arvill A, Lennquist C. Circulatory changes during high thoracic epidural anaesthesia – influence of sympathetic block and of systemic effect of the local anesthetic. Acta Anesthesiol Scand 1985;29:849-55. [Medline]
  15. Paech MJ, Pavy TJG, Orlikowski CEP, Kuh JYeo STLim K, et al. Post-operative intraspinal opioid analgesia after caesarean section; a randomised comparison of subarachnoid morphine and epidural pethedine. Int J Obstet Anaesth. 2009;9:238-245. [Medline]
  16. Haak-van der Lely F, van Kleef JW, Gesink-van der Veer BJ, Burm AG, Bovill JG. Efficacy of epidurally administered sufentanil versus bupivacaine during thoracic surgery. A randomized placebo-controlled double-blind study. Anaesthesia 1994;49:116-8. [Medline]
  17. Yegin A, Erdogan A, Kayacan N, Karsli B. Early postoperative pain management after thoracic surgery; pre and post operative versus post operative epidural analgesia: a randomized study. Eur J Cardiothorac Surg. 2003;24(3):420-4. [Medline]
  18. Chaney MA. Side effects of intrathecal and epidural opioids. Can J Anaesth. 1995 Oct;42(10):891-903. [Medline]
  19. Curatolo M, Schnider T, Petersen Flex S, Weiss SSigner CScaramozzino PZbinden AM. et al. A direct search procedure to optimize combinations of epidural bupivacaine, fentanyl and clonidine for postoperative analgesia. Anesthesiology 2000;92:325-37. [Medline]
  20. Lyons G, Columb M, Hawthorne L, Dresner M. Extradural pain relief in labour: bupivacaine sparing by extradural fentanyl is dose dependent. Br J Anaesth 1997;78:493-7. [Medline]
  21. Scott, D, Blake D, Buckland M et al. A comparison of epidural ropivacaine alone and in combination with 1, 2 and 4 g/ml fentanyl for 72 hrs of postoperative analgesia after major abdominal surgery. Anesth Analg 1995;81:973-81.
  22. Liu SS, Moore JM, Luo AM, Trautman WJCarpenter RL. et al. Comparison of three solutions of ropivacaine/fentanyl for postoperative patient controlled epidural analgesia. Anesthesiology 1999 Mar;90(3):727-33. [Medline]